Man­u­fac­tur­ing roundup: In­vest­ment firm buys Pfiz­er fa­cil­i­ty in Aus­tralia; Cam­brex opens new fa­cil­i­ty in Bel­gium

Pri­vate in­vest­ment firm Bridgewest Group has closed its ac­qui­si­tion of a for­mer Pfiz­er man­u­fac­tur­ing site out­side of Perth, Aus­tralia.

The new fa­cil­i­ty, lo­cat­ed in the Perth sub­urb of Bent­ley, will now op­er­ate as a CD­MO site un­der the name No­vaCi­na and will man­u­fac­ture ster­ile in­jectable drugs. The site has nine pro­duc­tion lines and a head­count of over 400 work­ers. No­vaCi­na al­so has plans to ex­pand its of­fer­ings by adding more equip­ment and an­a­lyt­i­cal ser­vices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER